Uterine adenofibroma and endometrial stromal sarcoma associated with tamoxifen therapy: MR findings.
Tamoxifen therapy may result in a variety of endometrial proliferative lesions, including adenofibroma and endometrial stromal sarcoma (ESS). This report describes the MR findings of adenofibroma and ESS associated with tamoxifen therapy. When MRI demonstrates a uterine mass appearing as a heterogeneous mass in the endometrium or myometrium, adenofibroma and ECC must be considered as rare, but possible, diagnoses.
Hayasaka
Kazumasa
K
Department of Radiology, National Center for Geriatrics and Gerontology, Japan. ckv37824@mopera.ne.jp
Morita
Kazuo
K
Saitoh
Tomoya
T
Tanaka
Yoshiaki
Y
D000232:Adenofibroma / Q000139:chemically induced* / Q000175:diagnosis; D000368:Aged; D000075202:Contraindications; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D018203:Sarcoma, Endometrial Stromal / Q000139:chemically induced* / Q000175:diagnosis; D013629:Tamoxifen / Q000008:administration & dosage; D014594:Uterine Neoplasms / Q000139:chemically induced* / Q000175:diagnosis
D013629:Tamoxifen